Adds 258,000 sq.-ft. to current Cookeville footprint and represents expansion into biologics, cold chain storage and third-party logistics distribution.
Site adds North American capability in product and process development, manufacturing and packaging of solid oral dosage forms, liquids, creams, and ointments.